It was unclear whether the Hb cut-off level of < 10.5 g/dL (a PEGASUS trial [14] entry criterion) was an appropriate cut-off level to determine whether PNH patients treated in NHS clinical practice have uncontrolled anaemia. The gene discussed is GSTM1; the disease is anemia (phenotype).